{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:06:12Z","timestamp":1790913972392,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T00:00:00Z","timestamp":1723939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jpba.2024.116410","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T06:24:48Z","timestamp":1723703088000},"page":"116410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Assessment of chemical stability of monoclonal antibody and antibody drug conjugate administered by pressurized intraperitoneal aerosol chemotherapy"],"prefix":"10.1016","volume":"251","author":[{"given":"Valentina","family":"D\u2019Atri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Buff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Imio\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Undurraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana Intidhar","family":"Labidi-Galy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy","family":"Guillarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Carrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2024.116410_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jpba.2024.116410_bib2","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jpba.2024.116410_bib3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejso.2017.03.019","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy \u2013 practical aspects","volume":"43","author":"H\u00fcbner","year":"2017","journal-title":"Eur. J. Surg. Oncol. EJSO"},{"key":"10.1016\/j.jpba.2024.116410_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102614","article-title":"Novel targets for immune-checkpoint inhibition in cancer","volume":"120","author":"Borgeaud","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jpba.2024.116410_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody\u2013drug conjugates come of age in oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpba.2024.116410_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00432-022-04412-4","article-title":"Pembrolizumab for all","volume":"149","author":"Kim","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jpba.2024.116410_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jchromb.2017.05.010","article-title":"Protocols for the analytical characterization of therapeutic monoclonal antibodies. I \u2013 Non-denaturing chromatographic techniques","volume":"1058","author":"Goyon","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116410_bib8","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/19420862.2017.1368602","article-title":"Forced degradation of recombinant monoclonal antibodies: a practical guide","volume":"9","author":"Nowak","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.jpba.2024.116410_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpba.2014.04.011","article-title":"Theory and practice of size exclusion chromatography for the analysis of protein aggregates","volume":"101","author":"Fekete","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116410_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464862","article-title":"Size exclusion chromatography of biopharmaceutical products: From current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles","volume":"1722","author":"D\u2019Atri","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2024.116410_bib11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchromb.2018.06.029","article-title":"Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins","volume":"1092","author":"Goyon","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116410_bib12","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jssc.202200075","article-title":"Direct coupling of size exclusion chromatography and mass spectrometry for the characterization of complex monoclonal antibody products","volume":"45","author":"Murisier","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jpba.2024.116410_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338987","article-title":"The importance of being metal-free: The critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry","volume":"1183","author":"Murisier","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jpba.2024.116410_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpba.2016.09.031","article-title":"Comprehensive study on the effects of sodium and potassium additives in size exclusion chromatographic separations of protein biopharmaceuticals","volume":"144","author":"Goyon","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116410_bib15","doi-asserted-by":"crossref","first-page":"13929","DOI":"10.1021\/acs.analchem.8b03333","article-title":"A novel online four-dimensional SEC\u00d7SEC-IM\u00d7MS methodology for characterization of monoclonal antibody size variants","volume":"90","author":"Ehkirch","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2024.116410_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.31083\/j.fbl2710290","article-title":"A combination of native LC-MS approaches for the comprehensive characterization of the antibody-drug conjugate trastuzumab deruxtecan","volume":"27","author":"Desligni\u00e8re","year":"2022","journal-title":"Front. Biosci. -Landmark"},{"key":"10.1016\/j.jpba.2024.116410_bib17","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4161\/mabs.2.6.13333","article-title":"Charge variants in IgG1: isolation, characterization, in vitro binding properties and pharmacokinetics in rats","volume":"2","author":"Khawli","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.jpba.2024.116410_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2174\/138920108786786402","article-title":"Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods","volume":"9","author":"Vlasak","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.jpba.2024.116410_bib19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.4161\/mabs.21328","article-title":"Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies","volume":"4","author":"Du","year":"2012","journal-title":"mAbs"},{"key":"10.1016\/j.jpba.2024.116410_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchromb.2017.09.033","article-title":"Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies","volume":"1065\u20131066","author":"Goyon","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116410_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpba.2015.02.037","article-title":"Ion-exchange chromatography for the characterization of biopharmaceuticals","volume":"113","author":"Fekete","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116410_bib22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/1078155219868516","article-title":"Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag","volume":"26","author":"Sundaramurthi","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.jpba.2024.116410_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202000464","article-title":"Effect of vitamins and metal ions on productivity and charge heterogeneity of IgG1 expressed in CHO cells","volume":"16","author":"Gangwar","year":"2021","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jpba.2024.116410_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpba.2016.04.004","article-title":"Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products","volume":"130","author":"Fekete","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2024.116410_bib25","series-title":"Antib.-Drug Conjug.","first-page":"147","article-title":"ADC analysis by hydrophobic interaction chromatography","author":"Fleming","year":"2020"},{"key":"10.1016\/j.jpba.2024.116410_bib26","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.bmcl.2016.02.020","article-title":"Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads","volume":"26","author":"Nakada","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jpba.2024.116410_bib27","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1158\/0008-5472.CAN-08-1776","article-title":"Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an antibody\u2013cytotoxic drug conjugate","volume":"68","author":"Lewis Phillips","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpba.2024.116410_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2023.123786","article-title":"A sensitive and rapid LC-MS\/MS assay for quantitation of free payload Aur0101 from antibody drug conjugate (ADC) PYX-201 in human plasma","volume":"1226","author":"Yin","year":"2023","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2024.116410_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41571-023-00783-w","article-title":"Optimizing the safety of antibody\u2013drug conjugates for patients with solid tumours","volume":"20","author":"Tarantino","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jpba.2024.116410_bib30","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/applbiosci2040040","article-title":"Unlocking insights into folding, structure, and function of proteins through circular dichroism spectroscopy\u2014a short review","volume":"2","author":"Linhares","year":"2023","journal-title":"Appl. Biosci."},{"key":"10.1016\/j.jpba.2024.116410_bib31","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1039\/D0CS00558D","article-title":"Tools and methods for circular dichroism spectroscopy of proteins: a tutorial review","volume":"50","author":"Miles","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jpba.2024.116410_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/gen.38.10.07","article-title":"Optimizing circular dichroism spectroscopy: provides key information on changes in secondary and tertiary structure of proteins","volume":"38","author":"Marshall","year":"2018","journal-title":"Genet. Eng. Biotechnol. N."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708524004503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T06:15:44Z","timestamp":1742192144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708524004503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"alternative-id":["S0731708524004503"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116410","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of chemical stability of monoclonal antibody and antibody drug conjugate administered by pressurized intraperitoneal aerosol chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2024.116410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116410"}}